Bioleaching of realgar nanoparticles using the extremophilic bacterium Acidithiobacillus ferrooxidans DLC-5
Reprint PDF

Keywords

Acidithiobacillus ferrooxidans
Bioleaching
Cancer
Chinese medicine
Dissolvability
Extremophilic bacterium
Leukemia
Mineral medicine
Nanoparticles
Nanotechnology
Realgar

How to Cite

1.
Song P, Wang J, Wu Z, Yan L, Zhao W, Liu Y, Ma W, Latta M, Li H, Chen P. Bioleaching of realgar nanoparticles using the extremophilic bacterium Acidithiobacillus ferrooxidans DLC-5. Electron. J. Biotechnol. [Internet]. 2019 Mar. 12 [cited 2024 Sep. 20];38. Available from: https://preprints.pucv.cl/index.php/ejbiotechnology/article/view/2019.01.001

Abstract

Background: This paper presents micro- and nano-fabrication techniques for leachable realgar using the extremophilic bacterium Acidithiobacillus ferrooxidans (A. ferrooxidans) DLC-5.

Results: Realgar nanoparticles of size ranging from 120 nm to 200 nm were successfully prepared using the highenergy ball mill instrument. A. ferrooxidans DLC-5 was then used to bioleach the particles. The arsenic concentration in the bioleaching system was found to be increased significantly when compared with that in the sterile control. Furthermore, in the comparison with the bioleaching of raw realgar, nanoparticles could achieve the same effect with only one fifth of the consumption.

Conclusion: Emphasis was placed on improving the dissolvability of arsenic because of the great potential of leachable realgar drug delivery in both laboratory and industrial settings.

Reprint PDF

Upon acceptance of an article by the journal, authors will be asked to transfer the copyright to Electronic Journal of Biotechnology, which is committed to maintain the electronic access to the journal and to administer a policy of fair control and ensure the widest possible dissemination of the information. The author can use the article for academic purposes, stating clearly the following: "Published in Electronic Journal of Biotechnology at DOI:10.2225/volXX-issueX-fulltext-XX".

The Copyright Transfer Agreement must be submitted as a signed scanned copy to biotec@ucv.cl. All authors must send a copy of this document.